High levels of OGT and its product, O-GlcNAcylation, were also reported in colon cancers and cancer cell lines (15, 19–21) and colitis-associated cancer patients (22) but very few initiatives to measure the effect of OGT knockdown were conducted. The gene discussed is OGT; the disease is malignant colon neoplasm.